Mesalamine Tablet, Delayed Release
Product Images NDC 54092-100

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 54092-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mesalamine 01)

Chemical structure diagram of the active ingredient mesalamine, showing its molecular arrangement with labeled functional groups including amino, hydroxyl, and carboxyl groups on a benzene ring.*

FDA Label Image

Principal Display Panel (1.2 g Tablet Bottle Label)

Label of Mesalamine delayed-release tablets, 1.2 g per tablet, oral dosage form by Takeda Pharmaceuticals America, Inc. The label states 120 tablets per package, marked Rx only, with storage instructions and warnings to keep out of reach of children. The product NDC is 54092-100-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.